Wingstop Inc. Revenue 2013–2025
Wingstop Inc. annual/quarterly revenue history and growth rate from 2013 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Wingstop Inc. revenue for the quarter ending March 28, 2026 was 183.7 M, a 7.38% increase year-over-year.
- Wingstop Inc. revenue for the twelve months ending March 28, 2026 was 704.9 M, a 21.30% increase year-over-year.
- Wingstop Inc. annual revenue for 2025 was 696.9 M, a 11.35% increase from 2024.
- Wingstop Inc. annual revenue for 2024 was 625.8 M, a 36.03% increase from 2023.
- Wingstop Inc. annual revenue for 2023 was 460.1 M, a 28.68% increase from 2022.
- Wingstop Inc. annual revenue for 2022 was 357.5 M.
West Pharmaceutical Services, Inc. (WING) — Frequently Asked Questions
West Pharmaceutical Services, Inc. (WING) is a publicly traded US company. It has a market capitalization of $4.33B. In fiscal 2025 it reported revenue of $697M and net income of $174M. Explore WING's stock price, financial statements, earnings history, margins and key ratios below.
What is West Pharmaceutical Services, Inc.'s market cap?
West Pharmaceutical Services, Inc. (WING) has a market capitalization of $4.33B.
What is the WING stock price?
WING trades at $154.25 (+5.95% on the day).
How much revenue does West Pharmaceutical Services, Inc. make?
West Pharmaceutical Services, Inc. reported revenue of $697M in fiscal 2025.
Is WING profitable?
In fiscal 2025, West Pharmaceutical Services, Inc. reported net income of $174M.